Skip to main content

Table 3 Factors that influence thromboembolic events by stepwise logistic regression method

From: Retrospective cohort study of the efficacy and safety of dabigatran: real-life dabigatran use including very low-dose 75 mg twice daily administration

Factor

Adjusted ODDS ratio

95% CI

P-value

Very low-dose (75 mg twice daily)

6.88

1.67–28.3

0.008*

H: Hypertension

2.25

0.83–6.12

0.110

A: Aged 75 or older

2.76

0.92–8.23

0.068

S: Stroke/TIA

2.97

1.11–7.94

0.030*

  1. *P < 0.05